0
Signin
countryflagUS

18889881171

AAPL 183.36 5.9701% MSFT 406.8 2.2522% GOOG 169.01 0.3265% GOOGL 167.21 0.3541% AMZN 186.235 0.8202% NVDA 887.83 3.4562% META 452.05 2.3479% TSLA 181.14 0.6277% TSM 141.56 3.9125% LLY 734.97 -2.7702% V 268.47 0.3214% AVGO 1278.11 3.1924% JPM 190.51 -0.6% UNH 492.45 -0.1055% NVO 123.05 -0.7821% WMT 59.82 0.1842% LVMUY 168.5 2.1584% XOM 116.02 -0.1893% LVMHF 841.0 1.8789% MA 443.58 0.5622%

Cannabix Technologies Inc

Healthcare US BLOZF

0.335USD
-0.017(4.83%)

Last update at 2024-05-03T19:35:00Z

Day Range

0.340.36
LowHigh

52 Week Range

0.120.39
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Income before tax -2.13812M -3.36771M -9.24345M -6.97079M -3.88050M
Minority interest - - - - 0.00000M
Net income -2.13812M -3.36771M -9.24345M -6.97079M -3.88050M
Selling general administrative 0.68M 2.11M 8.18M 1.98M 2.84M
Selling and marketing expenses - - - - -
Gross profit - - - - 0.00000M
Reconciled depreciation 0.13M 0.03M 0.03M 0.02M 0.02M
Ebit -2.13739M -3.39643M -9.30997M -3.18207M -4.01646M
Ebitda -1.97515M -3.36722M -9.28440M -3.16067M -3.99613M
Depreciation and amortization - 0.03M 0.03M 0.02M 0.02M
Non operating income net other - - - - 0.00000M
Operating income -2.27764M -3.39643M -9.30997M -3.18207M -4.01646M
Other operating expenses - 3.40M 9.31M 3.18M 4.02M
Interest expense 0.04M 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income 0.18M 0.03M 0.07M 0.10M 0.14M
Net interest income 0.14M 0.03M 0.07M 0.10M 0.14M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense - - - -0.10445M 0.00000M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 2.28M 3.40M 9.31M 3.18M 4.02M
Cost of revenue - - - - 0.00000M
Total other income expense net - 0.03M 0.07M -3.89316M 0.14M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -2.13812M -3.36771M -9.24345M -6.97079M -3.88050M
Net income applicable to common shares -2.13812M -3.36771M -9.24345M -6.97079M -3.88050M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Total assets 6.95M 8.76M 10.38M 8.74M 14.56M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets - - - - 0.00000M
Total liab 0.24M 0.12M 0.08M 0.09M 0.21M
Total stockholder equity 6.71M 8.64M 10.30M 8.64M 14.34M
Deferred long term liab - - - - 3.89M
Other current liab - - - - 0.00000M
Common stock 33.27M 33.27M 32.14M 22.02M 21.82M
Capital stock 33.27M 33.27M 32.14M 22.02M 21.82M
Retained earnings -34.32117M -32.18305M -28.81534M -19.57190M -12.60111M
Other liab - - - - 0.00000M
Good will - - - - 0.00000M
Other assets 0.05M 0.05M 0.05M - 3.89M
Cash 6.47M 8.45M 10.10M 8.44M 10.27M
Cash and equivalents - - - - -
Total current liabilities 0.23M 0.12M 0.08M 0.09M 0.21M
Current deferred revenue - - - - -
Net debt - -8.45416M -10.09508M -8.43710M -10.27271M
Short term debt - - - - 0.00000M
Short long term debt - - - - 0.00000M
Short long term debt total - - - - -
Other stockholder equity 7.76M 7.56M 6.98M 6.20M 5.13M
Property plant equipment 0.31M 0.19M 0.22M 0.17M 0.19M
Total current assets 6.59M 8.52M 10.12M 8.57M 10.48M
Long term investments - - - - 0.00000M
Net tangible assets 6.71M 8.64M 10.30M 8.64M 14.34M
Short term investments - - - - 0.00000M
Net receivables 0.05M 0.05M 0.01M 0.10M 0.19M
Long term debt - - - - 0.00000M
Inventory - - - - 0.00000M
Accounts payable 0.10M 0.12M 0.08M 0.09M 0.21M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 0.05M 0.05M 0.05M - 3.89M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 0.36M 0.24M 0.26M 0.17M 4.08M
Capital lease obligations 0.13M - - - 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Type yearly yearly yearly yearly yearly
Date 2023-04-30 2022-04-30 2021-04-30 2020-04-30 2019-04-30
Investments -0.02865M -0.00459M -0.12181M 0.00000M -0.05641M
Change to liabilities -0.01621M 0.04M -0.01145M -0.12114M 0.03M
Total cashflows from investing activities -0.02865M -0.00459M -0.12181M -0.12181M -0.05641M
Net borrowings -0.12412M -0.12412M -0.12412M -0.12412M 0.00000M
Total cash from financing activities 0.01M 0.49M 3.49M 0.06M 1.16M
Change to operating activities -0.04534M -0.01210M 0.03M -0.02675M 0.00451M
Net income -2.13812M -3.36771M -9.24345M -6.97079M -3.88050M
Change in cash -1.98422M -1.64092M 1.66M -1.83561M -0.72579M
Begin period cash flow 8.45M 10.10M 8.44M 10.27M 11.00M
End period cash flow 6.47M 8.45M 10.10M 8.44M 10.27M
Total cash from operating activities -1.96645M -2.12883M -1.71021M -1.89436M -1.82720M
Issuance of capital stock 0.14M 0.49M 3.49M 0.06M 1.16M
Depreciation 0.13M 0.03M 0.03M 0.02M 0.02M
Other cashflows from investing activities - - -0.04600M -0.04600M -0.04600M
Dividends paid - - - - 0.00000M
Change to inventory - - - - 0.00000M
Change to account receivables -0.00320M -0.03197M 0.08M 0.10M -0.14810M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities - -0.00459M -0.12181M - -0.05641M
Change to netincome 0.11M 1.21M 7.41M 1.21M 2.15M
Capital expenditures 0.03M 0.00459M 0.08M 0.08M 0.06M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -0.06475M -0.00400M 0.10M -0.05026M -0.11694M
Stock based compensation 0.07M 1.21M 0.81M 1.21M 2.15M
Other non cash items 0.04M - 6.60M 3.89M -
Free cash flow -1.99510M -2.13342M -1.78602M -1.89436M -1.88360M

Fundamentals

  • Previous Close 0.35
  • Market Cap15.38M
  • Volume72575
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.42898M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM -6.60000M
  • Diluted EPS TTM-0.02

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
BLOZF
Cannabix Technologies Inc		 -0.017 4.83% 0.34 - - - 3.62 -4.831
ABT
Abbott Laboratories		 -0.02 0.02% 105.90 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 1.82 0.56% 328.45 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.77 0.95% 81.69 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.83 1.15% 72.86 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use; MS breath sampler; and contactless alcohol breathalyzer, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

Cannabix Technologies Inc

3292 Production Way, Burnaby, BC, Canada, V5A 4R4

Key Executives

Name Title Year Born
Mr. Ravinder S. Mlait B.A., BA, M.B.A., MBA CEO & Director 1976
Mr. Kulwant Sing Malhi Pres & Director 1967
Mr. Bryan E. Loree B.A., C.M.A., CPA, CMA CFO, Corp. Sec. & Director 1976
Dr. Rajpaul Attariwala M.D., Ph.D. Chief Scientific Officer & Director 1968
Dr. Moe Paknahad Ph.D. VP of Technology Devel. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).